Insulet
PODD
#1074
Rank
NZ$35.82 B
Marketcap
NZ$508.88
Share price
-0.67%
Change (1 day)
12.46%
Change (1 year)
Categories
Insulet Corporation is an American company that develops and sells medical devices used for the administration of insulin.

EPS for Insulet (PODD)

EPS in 2025 (TTM): NZ$6.10

According to Insulet's latest financial reports the company's current EPS (TTM) is NZ$6.05. In 2024 the company made an earnings per share (EPS) of NZ$10.34 an increase over its 2023 EPS that were of NZ$5.10.

EPS history for Insulet from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ$6.10-41.03%
2024NZ$10.34102.71%
2023NZ$5.104114.29%
2022NZ$0.12-69.57%
2021NZ$0.40109.09%
2020NZ$0.19-38.89%
2019NZ$0.31200%
2018NZ$0.10-113.04%
2017NZ-$0.80-9.8%
2016NZ-$0.88-60.47%
2015NZ-$2.2338.71%
2014NZ-$1.6112.05%
2013NZ-$1.44-23.15%
2012NZ-$1.87-12.2%
2011NZ-$2.13

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
ICU Medical
ICUI
NZ-$0.54-108.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Tandem Diabetes Care
TNDM
NZ-$5.28-187.14%๐Ÿ‡บ๐Ÿ‡ธ USA
DexCom
DXCM
NZ$3.20-47.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
NZ$18.06 198.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
NZ$13.94 130.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
NZ$6.28 3.71%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Eli Lilly
LLY
NZ$35.49 486.24%๐Ÿ‡บ๐Ÿ‡ธ USA